AzTrials
AzTrials

ObesityNCT03305237

The Meal Time Study

A study testing Big Breakfast and Big Dinner in people with Obesity and Weight Loss, run by University of Aberdeen at 1 site in United Kingdom.

Completed

Finished. The study has ended and is not enrolling. Results may be posted on the official record.

Official record
Search all trials

Trial summary

This weight loss study will investigate the impact of calorie distribution across a day (large breakfast meals and smaller evening meals versus small breakfast meals and large evening meals) on body weight, and physiological and behavioral mechanisms regulating energy balance. Read more about this study

Who is it for?
Ages 18 to 75 yearsHealthy volunteers can take part
Conditions the study is for
Obesity, Weight Loss
What is being tested?
Big Breakfast and Big Dinner
Could I receive a placebo?
No, everyone receives an active treatment
How many people
31 participants
Where
1 siteUnited Kingdom
Study dates
24 Oct 2017to 28 Feb 2020
Phase
Interventional
Are there results?
None posted in the registry

Key requirements

Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.

  • Ages 18 to 75 years
  • All sexes
  • Healthy volunteers accepted
  • Adult, Older adult

Who may be able to join

  • BMI ranging from 27-42 kg/m2;
  • Those habitually consuming breakfast (at least 5 times a week).

Who cannot join

  • women who are pregnant, planning to be pregnant or breastfeeding
  • subjects with food allergies which prevent consumption of the study diet.
  • diagnosis of diabetes, hypertension, renal, hepatic, haematological disease, coronary heart disease, metabolic disease, gastrointestinal disease
  • having given a pint of blood for transfusion purposes within the last month
  • unsuitable veins for blood sampling
  • inability to understand the participant information sheet
Show all 11Show fewer
  • inability to speak, read and understand the English language
  • those on any prescription medications (other than oral contraceptives) which will adversely affect the study outcomes (i.e. medications affecting, circadian timing, sleep or metabolic function).
  • those on any specific diet regimes
  • those on any weight loss programmes (that may be affecting lifestyle, physical activity and diet).
  • Extremes of chronotypes, sleep patterns and physical activity.

Trial locations and contacts

1 site in 1 country.

United Kingdom1 site
  • The Rowett Institute

    Aberdeen, AB25 2ZD

Other trials in United Kingdom

About this study

Official title: The Big Breakfast Study: Chrono-nutrition Influence on Energy Expenditure and Body Weight

This weight loss study will investigate the impact of calorie distribution across a day (large breakfast meals and smaller evening meals versus small breakfast meals and large evening meals) on body weight, and physiological and behavioral mechanisms regulating energy balance.

Participants will undergo 2 x 4 week energy restriction protocols in a randomized cross over design; big breakfast (45% of calories in the morning meal, 20% at dinner) and big dinner (45% of calories in the evening meal, 20% at breakfast). We predict that timing of eating will influence energy balance, because morning energy expenditure is amplified in comparison to the evening. This study will allow us to assess whether the increased energy expenditure in the morning is linked to natural biological circadian rhythm or behavioral adaptions.

Read the detailed description

Dietary advice for weight management is broadly based on the assumption that a 'calorie is a calorie' and it does not matter when calories are consumed across the day. Recent evidence has challenged this assumption, suggesting that we may utilize calories more efficiently when consumed in the morning relative to the evening, and this could be used as a beneficial strategy for weight loss - this is a newly developing field of investigation which merges circadian biology with nutrition (chrono-nutrition).

Timing of food consumption is a modifiable factor influencing energy balance and body weight (and thus, disease risk). Previous research has shown that calories ingested at different times of the day have different effects on energy utilization, leading to differential weight loss, even at iso-caloric amounts. This study will aim to increase our understanding of the underlying behavioral and physiological mechanisms associated with differential weight loss and energy balance when calories are consumed predominantly in the morning versus in the evening.

This study will be a cross-over study comparing large breakfast versus large evening meals (percent daily calories split between breakfast, lunch and dinner as 45-35-20 (breakfast-loaded) or 20-35-45 (evening-loaded)) during energy restriction (Fed to measured RMR) on energy balance, through differences in both physiological and behavioural changes in energy expenditure and substrate utilization.

Conditions
Obesity, Weight Loss
Being tested
Big Breakfast, Big Dinner
Keywords
Weight loss, Chrono-nutrition, Diet, energy expenditure
Medical subject headings
Obesity, Weight Loss

What participants receive

What participants receive. In a randomised study each person is assigned to one group by chance.

  • Big BreakfastOther

    Weight loss diet (Calories fed to measured RMR) with calories distributed predominantly at breakfast (percent daily calories split between breakfast, lunch and dinner as 45-35-20%). The diet will be high protein (30% protein, 35% fat and 35% CHO) with all meals provided.

  • Big DinnerOther

    Weight loss diet (Calories fed to measured RMR) with calories distributed predominantly at dinner (percent daily calories split between breakfast, lunch and dinner as 20-35-45%). The diet will be high protein (30% protein, 35% fat and 35% CHO) with all meals provided.

Study groups in NCT03305237
Study groupRoleWhat they receive
big breakfast (BB) to big dinner (BD)ExperimentalPhase 1: no intervention, habitual diet for 4 days and then 4day maintenance diet Phase 2: consumption of BB energy restriction diets for 4 weeks Phase 3: washout for 1 week, controlled maintenance diet Phase 4: consumption of BD energy restriction diets for 4 weeks
Receives: Other: Big Breakfast; Other: Big Dinner
big dinner (BD) to big breakfast (BB)ExperimentalPhase 1: no intervention, habitual diet for 4 days and then 4day maintenance diet Phase 2: consumption of BD energy restriction diets for 4 weeks Phase 3: washout for 1 week, controlled maintenance diet Phase 4: consumption of BB energy restriction diets for 4 weeks
Receives: Other: Big Breakfast; Other: Big Dinner

What is being measured

The primary outcome is the main question the study is designed to answer.

  1. Energy balance

    Change in energy balance during each diet protocol (body weight (kg))

    Measured: Measured up to day 71 of study

Secondary outcomes (18)
  1. Total Daily Energy Expenditure

    Total energy expenditure measured by DLW for the 4 week BB and BD diet phases

    Measured: 4 x 2 weeks. Throughout weeks 2-5 and 7-10.

  2. Resting Metabolic Rate (RMR)

    RMR measured with indirect calorimetry (ventilated hood)

    Measured: Baseline,week 1, week 5, week 6, week 10.

  3. Thermic effect of food (TEF)

    TEF measured with indirect calorimetry (ventilated hood) for 6 hours after a breakfast meal

    Measured: Week 1, week 5, week 6, week 10.

  4. Body Volume

    Measured with Air Displacement plethysmography (BODPOD),

    Measured: Week 1, week 5, week 6, week 10.

  5. Bone Mineral Content

    Measured with Dual energy x-ray absorptiometry (DEXA)

    Measured: Week 1, week 5, week 6, week 10.

  6. Total Body Water

    Measured with deuterium dilution

    Measured: Week 1, week 5, week 6, week 10.

  7. Body Composition

    4 compartment model to assess changes in body composition (Combined from the measures of body weight, body volume, total body water and bone mineral)

    Measured: Week 1, week 5, week 6, week 10.

  8. Gastric emptying

    Gastric emptying measured using stable isotope, Octanoic acid labelled breath samples.

    Measured: Week 1, week 5, week 6, week 10.

  9. Waist and hip circumference

    Change in waist and hip circumferences and waist to hip ratio

    Measured: Week 1, week 5, week 6, week 10.

  10. Gut appetite hormones

    Change in plasma fasting and 2 hr post-meal appetite hormones

    Measured: Week 1, week 5, week 6, week 10.

  11. Plasma glucose

    Change in plasma fasting and 2 hr post-meal glucose

    Measured: Week 1, week 5, week 6, week 10.

  12. Plasma insulin

    Change in plasma fasting and 2 hr post-meal insulin

    Measured: Week 1, week 5, week 6, week 10.

  13. Blood lipids

    Change in plasma fasting and 2 hr post-meal blood lipids

    Measured: Week 1, week 5, week 6, week 10.

  14. Daily Subjective Appetite

    Changes in subjective appetite (hunger, fullness, desire to eat) measured using visual analogue scale questionnaires every waking hour for 3 days.

    Measured: Hourly measures for 3 days in week 1,week 5, week 6, week 10.

  15. Postprandial Subjective Appetite

    Changes in subjective appetite (hunger, fullness, desire to eat) measured using visual analogue scale questionnaires every 30 minutes for 6 hours after test meals.

    Measured: Week 1, week 5, week 6, week 10.

  16. Faecal sample analysis for gut health

    Chronic influence on changes in gut microbiota

    Measured: Week 1, week 5, week 6, week 10.

  17. Physical activity

    Change in physical activity levels measured with accelerometer (actigraph)

    Measured: Measured continuously for 24 hours for 3 days in week 1,week 5, week 6, week 10.

  18. 24 hour blood glucose

    Changes in 24 hour blood glucose levels measured with a continuous glucose monitor

    Measured: Measured continuously for 24 hours for 3 days in week 1,week 5, week 6, week 10.

Timeline

From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.

  1. First posted9 Oct 2017
  2. Study start24 Oct 2017
  3. Primary completion28 Feb 2020
  4. Study completion28 Feb 2020

Resources

More details

For doctors and researchers: how the study is designed, who runs it, and its registry IDs.

Study design
Study type
Interventional
Phase
Phase N/A
Primary purpose
Treatment
Allocation
Randomised
Intervention model
Crossover
Masking
Single blind
Who is masked
Participant
Enrolment
31 participants (actual)
IDs, dates and publications
ClinicalTrials.gov ID
NCT03305237
Sponsor's protocol ID
806
Other IDs
MR/P012205/1
Status last verified
Apr 2020
First submitted
26 Sep 2017
Last updated
6 Apr 2020
Results posted
No
Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
Individual data sharing
No

Publications

  • Ruddick-Collins LC, Morgan PJ, Fyfe CL, Filipe JAN, Horgan GW, Westerterp KR, Johnston JD, Johnstone AM. Timing of daily calorie loading affects appetite and hunger responses without changes in energy metabolism in healthy subjects with obesity. Cell Metab. 2022 Oct 4;34(10):1472-1485.e6. doi: 10.1016/j.cmet.2022.08.001. Epub 2022 Sep 9.

    PubMed 36087576

Questions about this trial

What is this clinical trial studying?

A study testing Big Breakfast and Big Dinner in people with Obesity and Weight Loss, run by University of Aberdeen at 1 site in United Kingdom.

The full registered description is in the About this study section and the official record.

Who may be eligible to take part?

The sponsor lists 2 inclusion and 11 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.

Is this clinical trial currently recruiting?

The record says: finished, as of the sponsor's last update on 6 Apr 2020. Status can change between updates, so confirm with the study contact before making plans.

Where is the study taking place?

The record lists 1 site in United Kingdom. Whether a site is taking part right now should be confirmed with that site. See every site.

What are the possible benefits and risks?

They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.

Are results available for this study?

The study is completed, but results are not available in the source record. That does not mean the treatment did or did not work.

How can a doctor refer a patient or contact the research team?

The record lists no contact. The official record names the sponsor, who can be asked directly. AzTrials does not enrol participants or take referrals.

What does the primary outcome measure?

Energy balance (time frame: Measured up to day 71 of study). It is what the study was designed to measure, not a finding.

Where can I read the original study information?

On the ClinicalTrials.gov record for NCT03305237, which also lists 1 linked publication.

Does a listing mean the treatment is approved or proven to work?

No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.

How often is this information updated?

AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 6 Apr 2020.

Free account

Keep searching with a free account

You’ve used your 3 free searches for this session. Log in or create a free AzTrials account to keep searching clinical trials and save the ones you want to follow.

Create a free accountLog in